The GNRH1 Knockout A-549 Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal population of A-549 cells harboring disruption of the gonadotropin-releasing hormone 1 (GNRH1) gene. This gene-edited product is designed as a loss-of-function model to facilitate interrogation of GNRH1-mediated signaling networks in a human lung adenocarcinoma background. The use of a polyclonal format ensures a diverse cellular population, providing robust and reproducible phenotypes for downstream experimental analysis.
The parental A-549 cell line is derived from a 58-year-old Caucasian male with lung adenocarcinoma and is widely employed as an alveolar epithelial cell model. These adherent cells retain key characteristics of Type II pneumocytes, making them a robust platform for studying epithelial signaling and cancer progression. Permanent disruption of GNRH1 in this host allows exploration of GnRH-mediated pathways in a pulmonary microenvironment.
GNRH1 encodes gonadotropin-releasing hormone (GnRH), a master regulator of reproductive function. GnRH binds the GNRHR receptor on pituitary gonadotropes, activating Gq/11 proteins that stimulate phospholipase C (PLC), generating inositol triphosphate (IP3) and diacylglycerol (DAG). This leads to calcium mobilization and protein kinase C (PKC) activation, driving MAPK/ERK signaling and promoting synthesis and secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Upstream regulators include kisspeptin, neurokinin B, and sex steroids, while downstream targets encompass LH beta, FSH beta, and GNRHR itself. Core signaling components include GNAQ/11, PLC, PKC, ERK, and calcium/calmodulin, which coordinate neuroendocrine feedback.
Although GNRH1 is central to reproductive neuroendocrinology, emerging evidence implicates GnRH signaling in hormone-dependent cancers, including prostate cancer. This knockout model in lung adenocarcinoma A-549 cells enables dissection of non-canonical GnRH functions, such as potential modulation of tumor cell proliferation or autocrine regulatory loops.
The knockout cells are amenable to RT-qPCR, hormone secretion assays, calcium imaging, reporter gene assays, and western blotting. Applications include reproductive biology, neuroendocrinology, hormone-dependent cancer research, and drug screening targeting GnRH pathways. For further technical information, please contact Ascent Research.
